[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Grunwald et al., 2023 - Google Patents

Development of Zika virus E variants for pseudotyping retroviral vectors targeting glioblastoma cells

Grunwald et al., 2023

View HTML
Document ID
826201781539332397
Author
Grunwald V
Ngo H
Formanski J
Jonas J
Pöhlking C
Schwalbe B
Schreiber M
Publication year
Publication venue
International Journal of Molecular Sciences

External Links

Snippet

A fundamental idea for targeting glioblastoma cells is to exploit the neurotropic properties of Zika virus (ZIKV) through its two outer envelope proteins, prM and E. This study aimed to develop envelope glycoproteins for pseudotyping retroviral vectors that can be used for …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein

Similar Documents

Publication Publication Date Title
Crawford et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays
Comas-Garcia et al. On the selective packaging of genomic RNA by HIV-1
Raza et al. Ivermectin inhibits bovine herpesvirus 1 DNA polymerase nuclear import and interferes with viral replication
Müller et al. A spotlight on viruses—application of click chemistry to visualize virus-cell interactions
Havranek et al. SARS-CoV-2 spike alterations enhance pseudoparticle titers and replication-competent VSV-SARS-CoV-2 virus
Aguilar-Hernández et al. Protein disulfide isomerase A4 is involved in genome uncoating during human astrovirus cell entry
Kretschmer et al. Zikavirus pr ME envelope pseudotyped human immunodeficiency virus type-1 as a novel tool for glioblastoma-directed virotherapy
Federspiel Reverse engineering provides insights on the evolution of subgroups A to E avian sarcoma and leukosis virus receptor specificity
Lainšček et al. A nanoscaffolded spike-rbd vaccine provides protection against sars-cov-2 with minimal anti-scaffold response
Caputo et al. Angiotensin II promotes SARS-CoV-2 infection via upregulation of ACE2 in human bronchial cells
Burnie et al. Flow virometry quantification of host proteins on the surface of HIV-1 pseudovirus particles
Grunwald et al. Development of Zika virus E variants for pseudotyping retroviral vectors targeting glioblastoma cells
Wang et al. Small structural proteins E and M render the SARS-CoV-2 pseudovirus more infectious and reveal the phenotype of natural viral variants
Chen et al. Efficient prodrug activator gene therapy by retroviral replicating vectors prolongs survival in an immune-competent intracerebral glioma model
Han et al. AAV13 enables precise targeting of local neural populations
Trevisan et al. Molecular requirements for self-interaction of the respiratory syncytial virus matrix protein in living mammalian cells
Bates et al. Engineering adenoviral vectors with improved GBM selectivity
Chongchai et al. Targeting human osteoarthritic chondrocytes with ligand directed bacteriophage-based particles
Zuo et al. Evolution of virology: science history through milestones and technological advancements
Gardner et al. In vitro and in vivo phenotypes of Venezuelan, eastern and western equine encephalitis viruses derived from cDNA clones of human isolates
Reale et al. Human monocytes are suitable carriers for the delivery of oncolytic herpes simplex virus type 1 in vitro and in a chicken embryo chorioallantoic membrane model of cancer
Pöhlking et al. Isolation of Cells from Glioblastoma Multiforme Grade 4 Tumors for Infection with Zika Virus prME and ME Pseudotyped HIV-1
Mamede et al. A new generation of functional tagged proteins for HIV fluorescence imaging
Galindo et al. Lipid exchange factors at membrane contact sites in African swine fever virus infection
Yin et al. BHK-21 cell clones differ in chikungunya virus infection and MXRA8 receptor expression